Differential effects of the estrogen receptor agonist estradiol on toxicity induced by enzymatically-derived or autoxidation-derived oxysterols in human ARPE-19 cells

Current Eye Research

Volumn 38, Issue 11, 2013, Pages 1159-1171

  Dasari, Bhanu ^a   Prasanthi, Jaya R P ^a   Meiers, Craig ^a   Singh, Brij B ^b   Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Age related macular degeneration; Estrogen receptor; IL 6; Liver X receptor; Oxysterols; TNF

Indexed keywords

25 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; 3 [3 [[2 CHLORO 3 (TRIFLUOROMETHYL)BENZYL](2 DIPHENYLETHYL)AMINO]PROPOXY]PHENYLACETIC ACID; 7 OXOCHOLESTEROL; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; INTERLEUKIN 6; INTERLEUKIN 8; LIVER X RECEPTOR; LIVER X RECEPTOR ALPHA; LIVER X RECEPTOR BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OXYSTEROL; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ARTICLE; AUTOOXIDATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WESTERN BLOTTING;

CELL LINE; CHEMOKINE CCL2; DRUG INTERACTIONS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; HYDROXYCHOLESTEROLS; INTERLEUKIN-6; INTERLEUKIN-8; KETOCHOLESTEROLS; MACULAR DEGENERATION; ORPHAN NUCLEAR RECEPTORS; OXIDATION-REDUCTION; PLATELET-DERIVED GROWTH FACTOR; RETINAL PIGMENT EPITHELIUM; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84884997331     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.811257     Document Type: Article

References (84)

1. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 2004;122:564-572
2. Connell PP, Keane PA, O'Neill EC, Altaie RW, Loane E, Neelam K, et al. Risk factors for age-related maculopathy. J Ophthalmol 2009;2009:360764. doi:10.1155/2009/360764
3. Evans J, Wormald R. Is the incidence of registrable agerelated macular degeneration increasing? Br J Ophthalmol 1996;80:9-14
4. Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB,Wang JJ, et al. The prevalence of age-related macular degeneration in Asians: A systematic review and meta-analysis. Ophthalmology 2010;117:921-927
5. Nirmalan PK, Katz J, Robin AL, Tielsch JM, Namperumalsamy P, Kim R, et al. Prevalence of vitreoretinal disorders in a rural population of southern India: The Aravind Comprehensive Eye Study. Arch Ophthalmol 2004;122:581-586
6. Rein DB, Wittenborn JS, Zhang X, Honeycutt AA, Lesesne SB, Saaddine J, et al. Forecasting age-related macular degeneration through the year 2050: The potential impact of new treatments. Arch Ophthalmol 2009;127:533-540
7. Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology 2001;108:697-704
8. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev 2005;85:845-881
9. Mares-Perlman JA, Brady WE, Klein R, VandenLangenberg GM, Klein BE, Palta M. Dietary fat and age-related maculopathy. Arch Ophthalmol 1995;113:743-748
10. Rudolf M, Curcio CA. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J Histochem Cytochem 2009;57:731-739
11. Curcio CA, Presley JB, Millican CL, Medeiros NE. Basal deposits and drusen in eyes with age-related maculopathy: Evidence for solid lipid particles. Exp Eye Res 2005;80: 761-775
12. Curcio CA, Presley JB, Malek G, Medeiros NE, Avery DV, Kruth HS. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp Eye Res 2005;81:731-741
13. Holz FG, Sheraidah G, Pauleikhoff D, Bird AC. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol 1994; 112:402-406
14. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human bruch's membrane. Invest Ophthalmol Vis Sci 2001;42:265-274
15. Malek G, Li CM, Guidry C, Medeiros NE, Curcio CA. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol 2003;162:413-425
16. Trivino A, Ramirez AI, Salazar JJ, de HR, Rojas B, Padilla E, et al. A cholesterol-enriched diet induces ultrastructural changes in retinal and macroglial rabbit cells. Exp Eye Res 2006;83:357-366
17. Javitt NB, Javitt JC. The retinal oxysterol pathway: A unifying hypothesis for the cause of age-related macular degeneration. Curr Opin Ophthalmol 2009;20:151-157
18. Dasari B, Prasanthi JR, Marwarha G, Singh BB, Ghribi O. Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol 2011;11:22. doi: 10.1186/1471-2415-11-22
19. Bjorkhem I, Meaney S, Diczfalusy U. Oxysterols in human circulation: Which role do they have? Curr Opin Lipidol 2002;13:247-253
20. Dasari B, Prasanthi J, Marwarha G, Singh B, Ghribi O. The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol 2010;10:22. doi: 10.1186/1471-2415-10- 22
21. Colles SM, Maxson JM, Carlson SG, Chisolm GM. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. Trends Cardiovasc Med 2001;11:131-138
22. Dugas B, Charbonnier S, Baarine M, Ragot K, Delmas D, Ménétrier F, et al. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: Cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur J Nutr 2010;49:435-446
23. Moreira EF, Larrayoz IM, Lee JW, Rodriguez IR. 7-Ketocholesterol is present in lipid deposits in the primate retina: Potential implication in the induction of VEGF and CNV formation. Invest Ophthalmol Vis Sci 2009;50: 523-532
24. Luthra S, Fardin B, Dong J, Hertzog D, Kamjoo S, Gebremariam S, et al. Activation of caspase-8 and caspase-12 pathways by 7-ketocholesterol in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2006;47: 5569-5575
25. Rodriguez IR, Alam S, Lee JW. Cytotoxicity of oxidized low-density lipoprotein in cultured rpe cells is dependent on the formation of 7-ketocholesterol. Invest Ophthalmol Vis Sci 2004;45:2830-2837
26. DuSell CD, Umetani M, Shaul PW, Mangelsdorf DJ, McDonnell DP. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol Endocrinol 2008;22:65-77
27. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL,Wright SD, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001;276:38378-38387
28. Song C, Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 2000;141: 4180-4184
29. Kim WS, Chan SL, Hill AF, Guillemin GJ, Garner B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J Alzheimers Dis 2009;16: 121-131
30. Umetani M, Domoto H, Gormley AK, Yuhanna IS, Cummins CL, Javitt NB, et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat Med 2007;13:1185-1192
31. Lappano R, Recchia AG, De Francesco EM, Angelone T, Cerra MC, Picard D, et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor a-mediated signaling in cancer cells and in cardiomyocytes. PLoS ONE 2011;6:e16631
32. Ogueta SB, Schwartz SD, Yamashita CK, Farber DB. Estrogen receptor in the human eye: Influence of gender and age on gene expression. Invest Ophthalmol Vis Sci 1999;40:1906-1911
33. Munaut C, Lambert V, Noe?l A, Frankenne F, Deprez M, Foidart JM, et al. Presence of oestrogen receptor type b in human retina. Br J Ophthalmol 2001;85:877-882
34. Bruce-Keller AJ, Keeling JL, Keller JN, Huang FF, Camondola S, Mattson MP. Antiinflammatory effects of estrogen on microglial activation. Endocrinology 2000;141: 3646-3656
35. Drew PD, Chavis JA. Female sex steroids: Effects upon microglial cell activation. J Neuroimmunol 2000;111:77-85
36. Sribnick EA, Ray SK, Banik NL. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res 2004;29:2007-2014
37. Kolsch H, Ludwig M, Lutjohann D, Rao ML. Neurotoxicity of 24-hydroxycholesterol, an important cholesterol elimination product of the brain, may be prevented by vitamin E and estradiol-17beta. J Neural Transm 2001;108:475-488
38. Chen W, Chen G, Head DL, Mangelsdorf DJ, Russell DW. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Cell Metab 2007;5: 73-79
39. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR[alpha]. Nature 1996;383:728-731
40. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, et al. Structural requirements of ligands for the oxysterol liver X receptors LXRa and LXRb. Proc Natl Acad Sci 1999;96:266-271
41. Smiley ST, Reers M, Mottola-Hartshorn C, Lin M, Chen A, Smith TW, et al. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregateforming lipophilic cation JC-1. Proc Natl Acad Sci U S A 1991;88:3671-3675
42. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the Jaggregate forming lipophilic cation 5,5',6,6'-tetrachloro- 1,1',3,3'-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 1993;197:40-45
43. Giddabasappa A, Bauler M, Yepuru M, Chaum E, Dalton JT, Eswaraka J. 17-b estradiol protects ARPE-19 cells from oxidative stress through estrogen receptor-b. Invest Ophthalmol Vis Sci 2010;51:5278-5287
44. Marin-Castano ME, Elliot SJ, Potier M, Karl M, Striker LJ, Striker GE, et al. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest Ophthalmol Vis Sci 2003;44:50-59
45. Dwyer MA, Kazmin D, Hu P, McDonnell DP, Malek G. Research resource: Nuclear receptor atlas of human retinal pigment epithelial cells: Potential relevance to agerelated macular degeneration. Mol Endocrinol 2011;25: 360-372
46. Paimela T, Hyttinen JM, Viiri J, Ryhanen T, Karvonen MK, Unkila M, et al. Influence of selective estrogen receptor modulators on interleukin-6 expression in human retinal pigment epithelial cells (ARPE-19). Eur J Pharmacol 2010; 640:219-225
47. Russell DW. Oxysterol biosynthetic enzymes. Biochim Biophys Acta 2000;1529:126-135
48. Karuna R, Holleboom AG, Motazacker MM, Kuivenhoven JA, Frikke-Schmidt R, Tybjaerg-Hansen A, et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis 2011;214:448-455
49. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999;142:1-28
50. Lund E, Bjorkhem I, Furster C, Wikvall K. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. Biochim Biophys Acta 1993;1166:177-182
51. Lund EG, Guileyardo JM, Russell DW. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc Natl Acad Sci U S A 1999;96: 7238-7243
52. Bretillon L, Diczfalusy U, Bjorkhem I, Maire MA, Martine L, Joffre C, et al. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr Eye Res 2007;32:361-366
53. Lee JW, Fuda H, Javitt NB, Strott CA, Rodriguez IR. Expression and localization of sterol 27-hydroxylase (CYP27A1) in monkey retina. Exp Eye Res 2006;83:465-469
54. Rodriguez IR, Larrayoz IM. Cholesterol oxidation in the retina: Implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J Lipid Res 2010;51:2847-2862
55. Vejux A, Malvitte L, Lizard G. Side effects of oxysterols: Cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz J Med Biol Res 2008;41:545-556
56. Ong JM, Aoki AM, Seigel GM, Sacerio I, Castellon R, Nesburn AB, et al. Oxysterol-induced toxicity in R28 and ARPE-19 cells. Neurochem Res 2003;28:883-891
57. Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008;126:519-524
58. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: Results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25:S13-S15
59. Klein BE, Klein R, Jensen SC, Ritter LL. Are sex hormones associated with age-related maculopathy in women? The Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1994;92: 289-295
60. Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: A case-control study. BMJ 1995;310: 1570-1571
61. Dimayuga FO, Reed JL, Carnero GA, Wang C, Dimayuga ER, Dimayuga VM, et al. Estrogen and brain inflammation: Effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol 2005;161: 123-136
62. Moosmann B, Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc Natl Acad Sci U S A 1999;96:8867-8872
63. Azcoitia I, Arevalo MA, De Nicola AF, Garcia-Segura LM. Neuroprotective actions of estradiol revisited. Trends Endocrinol Metab 2011;22:467-473
64. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-1312
65. Gramajo AL, Zacharias LC, Neekhra A, Luthra S, Atilano SR, Chwa M, et al. Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci 2010;51:1164-1170
66. Strehlow K, Rotter S, Wassmann S, Adam O, Grohe C, Laufs K, et al. Modulation of antioxidant enzyme expression and function by estrogen. Circ Res 2003;93:170-177
67. Fernando RI, Wimalasena J. Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol Biol Cell 2004;15:3266-3284
68. Vasconsuelo A, Milanesi L, Boland R. 17b-Estradiol abrogates apoptosis in murine skeletal muscle cells through estrogen receptors: Role of the phosphatidylinositol 3-kinase/Akt pathway. J Endocrinol 2008;196:385-397
69. Urata Y, Ihara Y, Murata H, Goto S, Koji T, Yodoi J, et al. 17b-estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 Cells. J Biol Chem 2006;281:13092-13102
70. Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA. Mitochondria play a central role in estrogeninduced neuroprotection. Curr Drug Targets CNS Neurol Disord 2005;4:69-83
71. Flynn JM, Dimitrijevich SD, Younes M, Skliris G, Murphy LC, Cammarata PR. Role of wild-type estrogen receptorbeta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab 2008;295:E637-E647
72. Rosklint T, Ohlsson BG, Wiklund O, Noren K, Hulten LM. Oxysterols induce interleukin-1beta production in human macrophages. Eur J Clin Invest 2002;32:35-42
73. Izumi-Nagai K, Nagai N, Ozawa Y, Mihara M, Ohsugi Y, Kurihara T, et al. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3(STAT3) promotes choroidal neovascularization. Am J Pathol 2007;170:2149-2158
74. Kim SM, Jang H, Son Y, Lee SA, Bae SS, Park YC, et al. 27-Hydroxycholesterol induces production of tumor necrosis factor-alpha from macrophages. Biochem Biophys Res Commun 2013;430:454-459
75. Prasanthi JR, Larson T, Schommer J, Ghribi O. Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27- hydroxycholesterol in rabbit hippocampus. PLoS One 2011;6:e26420. doi: 10.1371/journal.pone.0026420
76. Bjornstrom L, Sjoberg M. Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005;19:833-842
77. Levin ER. Invited review: Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 2001;91:1860-1867
78. Migliaccio A, Di DM, Castoria G, de FA, Bontempo P, Nola E, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996;15:1292-1300
79. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 2000;407:538-541
80. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001;20:6050-6059
81. Eisner A, Thielman EJ, Falardeau J, Vetto JT. Vitreo-retinal traction and anastrozole use. Breast Cancer Res Treat 2009; 117:9-16
82. Qiu QH, Chen ZY, Yin LL, Zheng Z, Wu XW. Effects of estrogen on collagen gel contraction by human retinal glial cells. Chin Med J (Engl) 2012;125:4098-4103
83. Chuo JY, Lee TY, Hollands H, Morris AH, Reyes RC, Rossiter JD, et al. Risk factors for posterior vitreous detachment: A case-control study. Am J Ophthalmol 2006; 142:931-937
84. Evans JR, Schwartz SD, McHugh JD, Thamby-Rajah Y, Hodgson SA, Wormald RP, et al. Systemic risk factors for idiopathic macular holes: A case-control study. Eye (Lond) 1998;12:256-259